{"id":751400,"date":"2023-04-26T10:07:58","date_gmt":"2023-04-26T14:07:58","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-the-h-c-wainwright-bioconnect-investor-conference-at-nasdaq\/"},"modified":"2023-04-26T10:07:58","modified_gmt":"2023-04-26T14:07:58","slug":"compass-therapeutics-to-participate-in-the-h-c-wainwright-bioconnect-investor-conference-at-nasdaq","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-the-h-c-wainwright-bioconnect-investor-conference-at-nasdaq\/","title":{"rendered":"Compass Therapeutics to Participate in the H.C. Wainwright BioConnect Investor Conference at NASDAQ"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">BOSTON, April  26, 2023  (GLOBE NEWSWIRE) &#8212; Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in the H.C. Wainwright BioConnect Investor Conference in New York City on Tuesday, May 2, 2023.<\/p>\n<p align=\"justify\">\n        <strong>Fireside Chat details:<br \/><\/strong><br \/>\n        <strong>Date: <\/strong>Tuesday, May 2<br \/><strong>Time: <\/strong>10 AM ET<br \/><strong>Webcast: <\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7MeVpNx8UOR1yhDs6pNsZShN51ODydTEr3Ue7KbH0r8xUWcgeg2ITX70_c2vAxUIw2YE0IVfPpLzg3CJKkOJUDRcQM-gLQE7U4RaGWRiYXl2Ef6RPOao7ZZj6LyImmA0wMn4gIgM2WFP4_PdF-Bg3x8-rpVMs7x6uJg6DHTC1HpEsjy_j2uLjRnkilPaHNElxMVY_3hdx1g6P0MMQV77bvcSjYWpGPA7HaBobVgj80k=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/journey.ct.events\/view\/059d01ae-0fdd-4419-8329-ac44f76cc2fc<\/a><\/p>\n<p>\n        <strong>Virtual\/Replay availability: <\/strong>The corporate presentation will be archived for 90 days on Compass\u2019 <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=a1Gj-C6Sd-ze1eQNpFxio7Q4IUcg-KoMis0O1jGyAKp1_KA152uHFdeo2tlxrZfwdNyA_p-3kwAAvQE0LOKsL_yN5Vxg7VzTBQe8qjRgDH1FPMENXv2Ys--LT5GlRDXG\" rel=\"nofollow noopener\" target=\"_blank\">Events<\/a> page.<\/p>\n<p>\n        <strong>About Compass Therapeutics<\/strong><br \/>\n        <br \/>Compass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. Compass\u2019s scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. Compass\u2019s pipeline of novel product candidates is designed to target multiple critical biological pathways required for an effective anti-tumor response. These include modulation of the microvasculature via angiogenesis-targeted agents, induction of a potent immune response via activators on effector cells in the tumor microenvironment, and alleviation of immunosuppressive mechanisms used by tumors to evade immune surveillance. Compass plans to advance its product candidates through clinical development as both standalone therapies and in combination with proprietary pipeline antibodies based on supportive clinical and nonclinical data. Compass was founded in 2014 and is headquartered in Boston, Massachusetts. For more information, visit the Compass Therapeutics, Inc. website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=soOD6dvZVdpxT0ZfYQzzZdVP6ZNN8SLkh_LfapNeASdHsymbumjmApR_SzzpIaxkXoxVlenphcoeyrdTr5JYHBl59GZg1AGlNzR1SN42haoaKw1gS3-6O_6Zyu8bvSEo\" rel=\"nofollow noopener\" target=\"_blank\">www.compasstherapeutics.com<\/a>.<\/p>\n<p>\n        <strong>Investor Contact<\/strong><br \/>\n        <br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ViAg9S0ihmAaSn_iT_L-4UAmgl9G89hh-mVkclwVz5ty7-U0uJPl5h_LFYjHE5qdVPwFq7aQNq5X4OFJ_IyQN2T7yypvbmzzVVyZf3mp1pK9muynX1jdSA_etGSILYHw\" rel=\"nofollow noopener\" target=\"_blank\">ir@compasstherapeutics.com<\/a>\n      <\/p>\n<p>\n        <strong>Media Contact<\/strong><br \/>\n        <br \/>Anna Gifford, Communications Manager<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jdAcQaIPoHmTiHhxolK9uj4HvisMqum8QnHpwnLTgZPTDuc6utn5gyAriy47b9Ejrm6rTDvIVJikxuwN9eRKZ83X6wQvzK2TK-NnrX1LnVYZxtUwy8CKB1KoFAlGMSOC\" rel=\"nofollow noopener\" target=\"_blank\">media@compasstherapeutics.com<\/a><br \/>617-500-8099<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNTY4NyM1NTU3Njg4IzIyMDI0MjI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/NmZjYjg0ODQtMTA3My00MWRjLWJjOGQtYTgxYzhjNTAzY2JlLTEyMTM5NzU=\/tiny\/Compass-Therapeutics.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BOSTON, April 26, 2023 (GLOBE NEWSWIRE) &#8212; Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in the H.C. Wainwright BioConnect Investor Conference in New York City on Tuesday, May 2, 2023. Fireside Chat details: Date: Tuesday, May 2Time: 10 AM ETWebcast: https:\/\/journey.ct.events\/view\/059d01ae-0fdd-4419-8329-ac44f76cc2fc Virtual\/Replay availability: The corporate presentation will be archived for 90 days on Compass\u2019 Events page. About Compass Therapeutics Compass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. Compass\u2019s scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. Compass\u2019s pipeline of novel product candidates is designed to &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-the-h-c-wainwright-bioconnect-investor-conference-at-nasdaq\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Compass Therapeutics to Participate in the H.C. Wainwright BioConnect Investor Conference at NASDAQ&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-751400","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Compass Therapeutics to Participate in the H.C. Wainwright BioConnect Investor Conference at NASDAQ - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-the-h-c-wainwright-bioconnect-investor-conference-at-nasdaq\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Compass Therapeutics to Participate in the H.C. Wainwright BioConnect Investor Conference at NASDAQ - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BOSTON, April 26, 2023 (GLOBE NEWSWIRE) &#8212; Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in the H.C. Wainwright BioConnect Investor Conference in New York City on Tuesday, May 2, 2023. Fireside Chat details: Date: Tuesday, May 2Time: 10 AM ETWebcast: https:\/\/journey.ct.events\/view\/059d01ae-0fdd-4419-8329-ac44f76cc2fc Virtual\/Replay availability: The corporate presentation will be archived for 90 days on Compass\u2019 Events page. About Compass Therapeutics Compass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. Compass\u2019s scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. Compass\u2019s pipeline of novel product candidates is designed to &hellip; Continue reading &quot;Compass Therapeutics to Participate in the H.C. Wainwright BioConnect Investor Conference at NASDAQ&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-the-h-c-wainwright-bioconnect-investor-conference-at-nasdaq\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-26T14:07:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNTY4NyM1NTU3Njg4IzIyMDI0MjI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-the-h-c-wainwright-bioconnect-investor-conference-at-nasdaq\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-the-h-c-wainwright-bioconnect-investor-conference-at-nasdaq\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Compass Therapeutics to Participate in the H.C. Wainwright BioConnect Investor Conference at NASDAQ\",\"datePublished\":\"2023-04-26T14:07:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-the-h-c-wainwright-bioconnect-investor-conference-at-nasdaq\\\/\"},\"wordCount\":259,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-the-h-c-wainwright-bioconnect-investor-conference-at-nasdaq\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyNTY4NyM1NTU3Njg4IzIyMDI0MjI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-the-h-c-wainwright-bioconnect-investor-conference-at-nasdaq\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-the-h-c-wainwright-bioconnect-investor-conference-at-nasdaq\\\/\",\"name\":\"Compass Therapeutics to Participate in the H.C. Wainwright BioConnect Investor Conference at NASDAQ - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-the-h-c-wainwright-bioconnect-investor-conference-at-nasdaq\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-the-h-c-wainwright-bioconnect-investor-conference-at-nasdaq\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyNTY4NyM1NTU3Njg4IzIyMDI0MjI=\",\"datePublished\":\"2023-04-26T14:07:58+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-the-h-c-wainwright-bioconnect-investor-conference-at-nasdaq\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-the-h-c-wainwright-bioconnect-investor-conference-at-nasdaq\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-the-h-c-wainwright-bioconnect-investor-conference-at-nasdaq\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyNTY4NyM1NTU3Njg4IzIyMDI0MjI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyNTY4NyM1NTU3Njg4IzIyMDI0MjI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/compass-therapeutics-to-participate-in-the-h-c-wainwright-bioconnect-investor-conference-at-nasdaq\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Compass Therapeutics to Participate in the H.C. Wainwright BioConnect Investor Conference at NASDAQ\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Compass Therapeutics to Participate in the H.C. Wainwright BioConnect Investor Conference at NASDAQ - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-the-h-c-wainwright-bioconnect-investor-conference-at-nasdaq\/","og_locale":"en_US","og_type":"article","og_title":"Compass Therapeutics to Participate in the H.C. Wainwright BioConnect Investor Conference at NASDAQ - Market Newsdesk","og_description":"BOSTON, April 26, 2023 (GLOBE NEWSWIRE) &#8212; Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in the H.C. Wainwright BioConnect Investor Conference in New York City on Tuesday, May 2, 2023. Fireside Chat details: Date: Tuesday, May 2Time: 10 AM ETWebcast: https:\/\/journey.ct.events\/view\/059d01ae-0fdd-4419-8329-ac44f76cc2fc Virtual\/Replay availability: The corporate presentation will be archived for 90 days on Compass\u2019 Events page. About Compass Therapeutics Compass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. Compass\u2019s scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. Compass\u2019s pipeline of novel product candidates is designed to &hellip; Continue reading \"Compass Therapeutics to Participate in the H.C. Wainwright BioConnect Investor Conference at NASDAQ\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-the-h-c-wainwright-bioconnect-investor-conference-at-nasdaq\/","og_site_name":"Market Newsdesk","article_published_time":"2023-04-26T14:07:58+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNTY4NyM1NTU3Njg4IzIyMDI0MjI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-the-h-c-wainwright-bioconnect-investor-conference-at-nasdaq\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-the-h-c-wainwright-bioconnect-investor-conference-at-nasdaq\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Compass Therapeutics to Participate in the H.C. Wainwright BioConnect Investor Conference at NASDAQ","datePublished":"2023-04-26T14:07:58+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-the-h-c-wainwright-bioconnect-investor-conference-at-nasdaq\/"},"wordCount":259,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-the-h-c-wainwright-bioconnect-investor-conference-at-nasdaq\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNTY4NyM1NTU3Njg4IzIyMDI0MjI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-the-h-c-wainwright-bioconnect-investor-conference-at-nasdaq\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-the-h-c-wainwright-bioconnect-investor-conference-at-nasdaq\/","name":"Compass Therapeutics to Participate in the H.C. Wainwright BioConnect Investor Conference at NASDAQ - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-the-h-c-wainwright-bioconnect-investor-conference-at-nasdaq\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-the-h-c-wainwright-bioconnect-investor-conference-at-nasdaq\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNTY4NyM1NTU3Njg4IzIyMDI0MjI=","datePublished":"2023-04-26T14:07:58+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-the-h-c-wainwright-bioconnect-investor-conference-at-nasdaq\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-the-h-c-wainwright-bioconnect-investor-conference-at-nasdaq\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-the-h-c-wainwright-bioconnect-investor-conference-at-nasdaq\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNTY4NyM1NTU3Njg4IzIyMDI0MjI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyNTY4NyM1NTU3Njg4IzIyMDI0MjI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/compass-therapeutics-to-participate-in-the-h-c-wainwright-bioconnect-investor-conference-at-nasdaq\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Compass Therapeutics to Participate in the H.C. Wainwright BioConnect Investor Conference at NASDAQ"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/751400","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=751400"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/751400\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=751400"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=751400"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=751400"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}